{"id":"https://openalex.org/W7204686697","doi":"https://doi.org/10.2174/0115734080483996260804061116","title":"FAK and PYK2 as Central Resistance Nodes in Non-Small Cell Lung Cancer: Signalling Crosstalk and Combination Therapeutic Strategies","display_name":"FAK and PYK2 as Central Resistance Nodes in Non-Small Cell Lung Cancer: Signalling Crosstalk and Combination Therapeutic Strategies","publication_year":2026,"publication_date":"2026-08-06","ids":{"openalex":"https://openalex.org/W7204686697","doi":"https://doi.org/10.2174/0115734080483996260804061116"},"language":"en","primary_location":{"id":"doi:10.2174/0115734080483996260804061116","doi":"https://doi.org/10.2174/0115734080483996260804061116","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0115734080483996260804061116","pdf_url":null,"source":{"id":"https://openalex.org/S192905621","display_name":"Current Enzyme Inhibition","issn_l":"1573-4080","issn":["1573-4080","1875-6662"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Enzyme Inhibition","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081054379","display_name":"Shatrudhan Prajapati","orcid":"https://orcid.org/0009-0003-6918-2789","observed_orcids":["https://orcid.org/0009-0003-6918-2789"]},"institutions":[{"id":"https://openalex.org/I182663762","display_name":"Lingaya's Vidyapeeth","ror":"https://ror.org/01vwns954","country_code":"IN","type":"education","lineage":["https://openalex.org/I182663762"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Shatrudhan Prajapati","raw_affiliation_strings":["School of Pharmacy, Lingaya\u2019s Vidyapeeth, Faridabad, Haryana, 121002, India"],"raw_orcid":"https://orcid.org/0009-0003-6918-2789","affiliations":[{"raw_affiliation_string":"School of Pharmacy, Lingaya\u2019s Vidyapeeth, Faridabad, Haryana, 121002, India","institution_ids":["https://openalex.org/I182663762"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132775874","display_name":"Shabana Khatoon","orcid":"https://orcid.org/0009-0006-5890-2957","observed_orcids":["https://orcid.org/0009-0006-5890-2957"]},"institutions":[{"id":"https://openalex.org/I182663762","display_name":"Lingaya's Vidyapeeth","ror":"https://ror.org/01vwns954","country_code":"IN","type":"education","lineage":["https://openalex.org/I182663762"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Shabana Khatoon","raw_affiliation_strings":["School of Pharmacy, Lingaya\u2019s Vidyapeeth, Faridabad, Haryana, 121002, India"],"raw_orcid":"https://orcid.org/0009-0006-5890-2957","affiliations":[{"raw_affiliation_string":"School of Pharmacy, Lingaya\u2019s Vidyapeeth, Faridabad, Haryana, 121002, India","institution_ids":["https://openalex.org/I182663762"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101862963","display_name":"Ajay Pal Singh","orcid":"https://orcid.org/0009-0008-1134-8498","observed_orcids":["https://orcid.org/0009-0008-1134-8498"]},"institutions":[{"id":"https://openalex.org/I182663762","display_name":"Lingaya's Vidyapeeth","ror":"https://ror.org/01vwns954","country_code":"IN","type":"education","lineage":["https://openalex.org/I182663762"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ajay Pal Singh","raw_affiliation_strings":["School of Pharmacy, Lingaya\u2019s Vidyapeeth, Faridabad, Haryana, 121002, India"],"raw_orcid":"https://orcid.org/0009-0008-1134-8498","affiliations":[{"raw_affiliation_string":"School of Pharmacy, Lingaya\u2019s Vidyapeeth, Faridabad, Haryana, 121002, India","institution_ids":["https://openalex.org/I182663762"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055986915","display_name":"Shikha Yadav","orcid":"https://orcid.org/0000-0002-2816-8273","observed_orcids":["https://orcid.org/0000-0002-2816-8273"]},"institutions":[{"id":"https://openalex.org/I155125381","display_name":"Galgotias University","ror":"https://ror.org/02w8ba206","country_code":"IN","type":"education","lineage":["https://openalex.org/I155125381"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Shikha Yadav","raw_affiliation_strings":["Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India"],"raw_orcid":"https://orcid.org/0000-0002-2816-8273","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India","institution_ids":["https://openalex.org/I155125381"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5081054379"],"corresponding_institution_ids":["https://openalex.org/I182663762"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.8744999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.8744999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.08919999748468399,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/focal-adhesion-kinase","display_name":"focal adhesion kinase","score":0.8939999938011169},{"id":"https://openalex.org/keywords/pyk2","display_name":"Pyk2","score":0.9710000157356262},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.9700000286102295},{"id":"https://openalex.org/keywords/signaling-crosstalk","display_name":"signaling crosstalk","score":0.9200000166893005},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.7360000014305115},{"id":"https://openalex.org/keywords/pi3k-akt","display_name":"PI3K/Akt","score":0.9760000109672546},{"id":"https://openalex.org/keywords/mitogen-activated-protein-kinase","display_name":"mitogen-activated protein kinase","score":0.9819999933242798},{"id":"https://openalex.org/keywords/jak-stat-signaling","display_name":"JAK/STAT signaling","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.925000011920929},{"id":"https://openalex.org/keywords/nanocarrier-drug-delivery","display_name":"nanocarrier drug delivery","score":0.9350000023841858},{"id":"https://openalex.org/keywords/epithelial-mesenchymal-transition","display_name":"epithelial-mesenchymal transition","score":0.9020000100135803},{"id":"https://openalex.org/keywords/biomarker-driven-patient-selection","display_name":"biomarker-driven patient selection","score":0.7580000162124634}],"concepts":[{"id":"https://openalex.org/C169822122","wikidata":"https://www.wikidata.org/wiki/Q230187","display_name":"Crosstalk","level":2,"score":0.6854000091552734},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6694999933242798},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5483999848365784},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.5408999919891357},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4706000089645386},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.43560001254081726},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.43549999594688416},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4260999858379364},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.39719998836517334},{"id":"https://openalex.org/C112392421","wikidata":"https://www.wikidata.org/wiki/Q903451","display_name":"Janus kinase","level":3,"score":0.3824000060558319},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.3666999936103821},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.3626999855041504},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.34220001101493835},{"id":"https://openalex.org/C150555746","wikidata":"https://www.wikidata.org/wiki/Q210973","display_name":"Cell signaling","level":3,"score":0.33869999647140503},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.3312999904155731},{"id":"https://openalex.org/C171958077","wikidata":"https://www.wikidata.org/wiki/Q419333","display_name":"STAT protein","level":4,"score":0.3255999982357025},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.3208000063896179},{"id":"https://openalex.org/C26375932","wikidata":"https://www.wikidata.org/wiki/Q118226","display_name":"Growth factor receptor","level":3,"score":0.3176000118255615},{"id":"https://openalex.org/C157333092","wikidata":"https://www.wikidata.org/wiki/Q902835","display_name":"JAK-STAT signaling pathway","level":4,"score":0.3158999979496002},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.30970001220703125},{"id":"https://openalex.org/C108636557","wikidata":"https://www.wikidata.org/wiki/Q21109354","display_name":"Proto-oncogene tyrosine-protein kinase Src","level":3,"score":0.305400013923645},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3001999855041504},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.30000001192092896},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2953000068664551},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.28369998931884766},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.27889999747276306},{"id":"https://openalex.org/C151166631","wikidata":"https://www.wikidata.org/wiki/Q904514","display_name":"Focal adhesion","level":3,"score":0.2711000144481659},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2696000039577484},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.2669000029563904},{"id":"https://openalex.org/C2776362946","wikidata":"https://www.wikidata.org/wiki/Q424374","display_name":"Epidermal growth factor","level":3,"score":0.2563000023365021},{"id":"https://openalex.org/C35174551","wikidata":"https://www.wikidata.org/wiki/Q7660502","display_name":"Syk","level":4,"score":0.25619998574256897},{"id":"https://openalex.org/C88045685","wikidata":"https://www.wikidata.org/wiki/Q174576","display_name":"Activator (genetics)","level":3,"score":0.25459998846054077},{"id":"https://openalex.org/C2781322055","wikidata":"https://www.wikidata.org/wiki/Q423725","display_name":"Phosphoinositide 3-kinase","level":4,"score":0.25459998846054077},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.25049999356269836}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2174/0115734080483996260804061116","doi":"https://doi.org/10.2174/0115734080483996260804061116","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0115734080483996260804061116","pdf_url":null,"source":{"id":"https://openalex.org/S192905621","display_name":"Current Enzyme Inhibition","issn_l":"1573-4080","issn":["1573-4080","1875-6662"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Enzyme Inhibition","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4403647847","https://openalex.org/W7124916481","https://openalex.org/W4415772243","https://openalex.org/W1593299612","https://openalex.org/W4413833780","https://openalex.org/W4399390026","https://openalex.org/W2170050492","https://openalex.org/W4415912398","https://openalex.org/W2136989592","https://openalex.org/W2296687919"],"abstract_inverted_index":{"Introduction:":[0],"Non-Small":[1],"Cell":[2],"Lung":[3],"Cancer":[4],"(NSCLC)":[5],"remains":[6],"a":[7,293],"major":[8,89],"clinical":[9,98,185,271,309],"challenge":[10],"and":[11,36,40,56,70,77,97,119,129,156,160,176,214,246,275,287,300,308],"is":[12,25,311],"one":[13],"of":[14,18,44,103,113,162,167,225,236,260],"the":[15,37,41,48,94,101,226,234,242,258],"leading":[16],"causes":[17],"cancer-related":[19],"mortality":[20],"worldwide.":[21],"Its":[22],"poor":[23],"prognosis":[24],"driven":[26],"by":[27,257],"substantial":[28],"molecular":[29],"heterogeneity,":[30],"dynamic":[31],"interactions":[32],"between":[33],"tumor":[34,75,298],"cells":[35],"surrounding":[38],"microenvironment,":[39],"frequent":[42],"development":[43],"therapeutic":[45,114,177,231,279,302,316],"resistance.":[46,178,252,303],"Among":[47],"signaling":[49,105,134,244],"pathways":[50,245],"involved,":[51],"Focal":[52],"Adhesion":[53],"Kinase":[54,59,149,154],"(FAK)":[55],"Proline-rich":[57],"tyrosine":[58,192],"2":[60],"(PYK2)":[61],"have":[62,200],"emerged":[63],"as":[64,132],"important":[65],"regulators":[66],"that":[67,136,249],"integrate":[68],"oncogenic":[69,139],"microenvironmental":[71],"signals,":[72],"thereby":[73],"promoting":[74],"progression":[76],"resistance":[78],"to":[79,92,251,269,296,313],"therapy.":[80],"Methods:":[81],"A":[82],"narrative":[83],"literature":[84],"review":[85],"was":[86],"conducted":[87],"using":[88],"scientific":[90],"databases":[91],"evaluate":[93],"mechanistic,":[95],"preclinical,":[96],"evidence":[99],"regarding":[100],"role":[102],"FAK/PYK2":[104,239],"in":[106,281,306],"NSCLC.":[107,237,282],"Studies":[108],"investigating":[109],"pathway":[110],"interactions,":[111],"mechanisms":[112,248],"resistance,":[115],"combination":[116,188,254],"treatment":[117,235],"strategies,":[118],"nanocarrier-mediated":[120],"drug":[121,212,289],"delivery":[122,208,290],"systems":[123,209],"were":[124],"critically":[125],"analyzed.":[126],"Results:":[127],"FAK":[128,274],"PYK2":[130,276],"function":[131],"central":[133],"hubs":[135],"connect":[137],"key":[138],"pathways,":[140],"including":[141],"Epidermal":[142],"Growth":[143],"Factor":[144],"Receptor":[145],"(EGFR),":[146],"Phosphoinositide":[147],"3-Kinase/Protein":[148],"B":[150],"(PI3K/AKT),":[151],"Mitogen-Activated":[152],"Protein":[153],"(MAPK),":[155],"Janus":[157],"Kinase/Signal":[158],"Transducer":[159],"Activator":[161],"Transcription":[163],"(JAK/STAT)":[164],"signaling.":[165],"Activation":[166],"these":[168],"kinases":[169],"promotes":[170],"cell":[171],"proliferation,":[172],"survival,":[173],"epithelial\u2013mesenchymal":[174],"transition,":[175],"Although":[179],"FAK/PYK2-targeted":[180],"monotherapy":[181],"has":[182],"demonstrated":[183],"limited":[184],"efficacy,":[186],"rational":[187,294],"strategies":[189,232],"involving":[190,284],"EGFR":[191],"kinase":[193],"inhibitors,":[194,196],"MAPK":[195],"chemotherapy,":[197],"or":[198],"immunotherapy":[199],"shown":[201],"promising":[202,278],"synergistic":[203],"effects.":[204],"In":[205],"addition,":[206],"nanocarrier-based":[207],"may":[210,240],"improve":[211],"targeting":[213],"pharmacokinetic":[215],"profiles":[216],"while":[217],"reducing":[218],"systemic":[219],"toxicity.":[220],"Discussion:":[221],"The":[222],"adaptive":[223],"quality":[224],"disease":[227],"calls":[228],"for":[229,233],"multi-pathway":[230,285],"Blocking":[238],"interrupt":[241],"integrated":[243],"compensatory":[247],"contribute":[250],"Precision-guided":[253],"regimens":[255],"aided":[256],"use":[259],"biomarker-driven":[261],"patient":[262],"selection":[263],"are":[264],"critical":[265],"when":[266],"it":[267],"comes":[268],"improving":[270],"outcomes.":[272],"Conclusion:":[273],"represent":[277],"targets":[280],"Strategies":[283],"inhibition":[286],"advanced":[288],"platforms":[291],"offer":[292],"approach":[295],"suppress":[297],"growth":[299],"overcome":[301],"Further":[304],"investigation":[305],"translational":[307],"settings":[310],"warranted":[312],"establish":[314],"their":[315],"potential.":[317]},"counts_by_year":[],"updated_date":"2026-09-21T07:43:02.447757","created_date":"2026-08-31T00:00:00"}